
    
      The drug being tested in this survey is called rasagiline tablet. This tablet is being tested
      to treat people with Parkinson's disease.

      This survey is an observational (non-interventional) study and will look at the long-term
      safety and efficacy of the rasagiline tablet in the routine clinical setting. The planned
      number of observed patients will be approximately 1000.

      This multi-center observational trial will be conducted in Japan.
    
  